ANT 005 TKA Trial: Abelacimab for VTE March 14, 2023 2021 ANT-005 TKA TRIAL M Abelacimab for Prevention of Venous Thromboembolism (VTE) Phase 2,open-label, prospective randomized trial 400 Objective: To compare the efficacy &...